Features
Eschenbach Optik of America Introduces its New Asensys® Absorptive Filters
Tuesday, March 5 2024 | 13 h 28 min | News,
Eschenbach introduces its new Asensys® filters, a line of contrast-enhancing eyewear designed to either fit over patients’ prescription glasses or be worn alone and provide all-round protection against the sun and unpleasant glare.
CooperVision GSLS 2024 Scientific Program Advances Myopia Control & Irregular Cornea Care
Tuesday, March 5 2024 | 10 h 46 min | News,
MiSight® 1 day Efficacy for Fast/Slow Progressors, Pediatric Prescribing Trends, and Scleral Lens Use for Dry Eye Among Research Papers and Posters Highlights
Latest CORE Publication Offers Specialty Contact Lens and Myopia Management Insights for Practitioners
Tuesday, March 5 2024 | 10 h 17 min | News,
Advancements in and increased fitting of scleral and corneo-scleral lenses, plus resurgent interest surrounding orthokeratology for managing myopia control, sets the stage for Issue 76 of Contact Lens Update.
Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science & Research,
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease.
Dynamic & Comprehensive VisionEd Conference Program Announced for VEE 2024
Monday, March 4 2024 | 15 h 54 min | News,
The Vision Council and RX, co-organizers of Vision Expo, bring compelling accredited continuing education offerings to the industry at Vision Expo East 2024.
Eschenbach Optik of America Introduces its New Asensys® Absorptive Filters
Tuesday, March 5 2024 | 13 h 28 min | News,
Eschenbach introduces its new Asensys® filters, a line of contrast-enhancing eyewear designed to either fit over patients’ prescription glasses or be worn alone and provide all-round protection against the sun and unpleasant glare.
CooperVision GSLS 2024 Scientific Program Advances Myopia Control & Irregular Cornea Care
Tuesday, March 5 2024 | 10 h 46 min | News,
MiSight® 1 day Efficacy for Fast/Slow Progressors, Pediatric Prescribing Trends, and Scleral Lens Use for Dry Eye Among Research Papers and Posters Highlights
Latest CORE Publication Offers Specialty Contact Lens and Myopia Management Insights for Practitioners
Tuesday, March 5 2024 | 10 h 17 min | News,
Advancements in and increased fitting of scleral and corneo-scleral lenses, plus resurgent interest surrounding orthokeratology for managing myopia control, sets the stage for Issue 76 of Contact Lens Update.
Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science & Research,
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease.
Dynamic & Comprehensive VisionEd Conference Program Announced for VEE 2024
Monday, March 4 2024 | 15 h 54 min | News,
The Vision Council and RX, co-organizers of Vision Expo, bring compelling accredited continuing education offerings to the industry at Vision Expo East 2024.
Eschenbach Optik of America Introduces its New Asensys® Absorptive Filters
Tuesday, March 5 2024 | 13 h 28 min | News,
Eschenbach introduces its new Asensys® filters, a line of contrast-enhancing eyewear designed to either fit over patients’ prescription glasses or be worn alone and provide all-round protection against the sun and unpleasant glare.
CooperVision GSLS 2024 Scientific Program Advances Myopia Control & Irregular Cornea Care
Tuesday, March 5 2024 | 10 h 46 min | News,
MiSight® 1 day Efficacy for Fast/Slow Progressors, Pediatric Prescribing Trends, and Scleral Lens Use for Dry Eye Among Research Papers and Posters Highlights
Latest CORE Publication Offers Specialty Contact Lens and Myopia Management Insights for Practitioners
Tuesday, March 5 2024 | 10 h 17 min | News,
Advancements in and increased fitting of scleral and corneo-scleral lenses, plus resurgent interest surrounding orthokeratology for managing myopia control, sets the stage for Issue 76 of Contact Lens Update.
Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science & Research,
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease.
Dynamic & Comprehensive VisionEd Conference Program Announced for VEE 2024
Monday, March 4 2024 | 15 h 54 min | News,
The Vision Council and RX, co-organizers of Vision Expo, bring compelling accredited continuing education offerings to the industry at Vision Expo East 2024.
Eschenbach Optik of America Introduces its New Asensys® Absorptive Filters
Tuesday, March 5 2024 | 13 h 28 min | News,
Eschenbach introduces its new Asensys® filters, a line of contrast-enhancing eyewear designed to either fit over patients’ prescription glasses or be worn alone and provide all-round protection against the sun and unpleasant glare.
CooperVision GSLS 2024 Scientific Program Advances Myopia Control & Irregular Cornea Care
Tuesday, March 5 2024 | 10 h 46 min | News,
MiSight® 1 day Efficacy for Fast/Slow Progressors, Pediatric Prescribing Trends, and Scleral Lens Use for Dry Eye Among Research Papers and Posters Highlights
Latest CORE Publication Offers Specialty Contact Lens and Myopia Management Insights for Practitioners
Tuesday, March 5 2024 | 10 h 17 min | News,
Advancements in and increased fitting of scleral and corneo-scleral lenses, plus resurgent interest surrounding orthokeratology for managing myopia control, sets the stage for Issue 76 of Contact Lens Update.
Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science & Research,
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease.
Dynamic & Comprehensive VisionEd Conference Program Announced for VEE 2024
Monday, March 4 2024 | 15 h 54 min | News,
The Vision Council and RX, co-organizers of Vision Expo, bring compelling accredited continuing education offerings to the industry at Vision Expo East 2024.
